Swartz:Research/VLPs: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
{{Template:Swartz}} | {{Template:Swartz}} | ||
The Virus-Like Particles team in the [[Swartz| Swartz Lab]] focuses on developing Biotechnology-based solutions using VLPs. Using the cell free protein synthesis platform, we are able to include non-natural amino acids into our VLPs allow for the direct bioconjugation of functional molecules to the surface. | The Virus-Like Particles team in the [[Swartz| Swartz Lab]] focuses on developing Biotechnology-based solutions using VLPs. Using the cell free protein synthesis platform, we are able to include non-natural amino acids into our VLPs allow for the direct bioconjugation of functional molecules to the surface. | ||
The VLP team currently consists of Wei Chan, Benjamin Ko, Yuan Lu, and Chris VanLang | The VLP team currently consists of Wei Chan, Benjamin Ko, Yuan Lu, and Chris VanLang |
Revision as of 18:50, 7 October 2011
Research | Papers | People | Contact |
The Virus-Like Particles team in the Swartz Lab focuses on developing Biotechnology-based solutions using VLPs. Using the cell free protein synthesis platform, we are able to include non-natural amino acids into our VLPs allow for the direct bioconjugation of functional molecules to the surface.
The VLP team currently consists of Wei Chan, Benjamin Ko, Yuan Lu, and Chris VanLang
We are curators of the nanomedicine group in Mendeley.
<html><iframe src="http://www.mendeley.com/groups/762661/_/widget/1/0/" frameborder="0" allowTransparency="true" style="width:260px;"></iframe><p style="width:260px"><a href="http://www.mendeley.com/groups/762661/nanomedicine/" title="Nanomedicine on Mendeley"></a></p></html>